Trinity Biotech | TRIB - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Bayer EUR 10.04B 168M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
EDAP TMS EUR 25.18M 6.37M 2026-03
J&J USD 17.83B 388M 2026-06
Mesa Laboratories USD 33.98M 2.03M 2024-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Plus Therapeutics USD 8.15M 1.04M 2026-03
Roche Holding CHF 18.9B 2.12B 2026-06
Siemens EUR 17.6B 531M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Tosoh JPY 242.99B 4.79B 2026-06
Trinity Biotech USD 12.38M 2.44M 2025-12
Veracyte USD 126.36M 6.37M 2026-06